Julius Knowles - Director at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julius Knowles since 11/19/2024

Holdings reported by Julius Knowles for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 233K $3.36M $14.44 Jun 4, 2025 Indirect
Common Stock 6.44K $93K $14.44 Jun 4, 2025 Direct
Stock Option (right to buy) 10.5K Jun 4, 2025 Direct Common Stock

Transactions reported by Julius Knowles for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.